Placental mesenchymal dysplasia – morphology and differential diagnosis

Česká verzia

Authors: Magdaléna Daumová ^1,2; Šárka Hadravská ^1,2; Andrea Straková Peteříková ¹; Marcel Hasch ^2,3; Petr Martínek ²
Authors place of work: Šiklův ústav patologie LFP UK a FN Plzeň ¹; Bioptická laboratoř s. r. o., Plzeň ²; Genetika Plzeň, s. r. o. ³
Published in the journal: Čes.-slov. Patol., 57, 2021, No. 4, p. 203-207
Category: Reviews Article

Summary

SUMMARY Placental mesenchymal dysplasia is a rare placental lesion characterized by placentomegaly, vascular abnormalities and formation of cystic structures in the placental parenchyma. It can be associated with various genetic abnormalities, fetal growth restriction or intrauterine fetal demise. Placental mesenchymal dysplasia needs to be distinguished from its main differential diagnosis, partial hydatidiform mole. The aim of this article is to provide readers with a basic overview of the morphology and differential diagnosis of this pathological entity.

Keywords:

Placenta – differential diagnosis – placental mesenchymal dysplasia – PMD – cystic lesions

Zdroje

1. Moscoso G, Jauniaux E, Hustin J. Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia. A new clinico-pathological entity? Pathol Res Pract 1991; 187(2-3): 324-328.

2. Parveen Z, Tongson-Ignacio JE, Fraser CR, Killeen JL, Thompson KS. Placental mesenchymal dysplasia. Arch Pathol Lab Med 2007; 131(1): 131-137.

3. Arizawa M, Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Congenit Anom 2002; 42(4): 309-317.

4. Zeng X, Chen MF, Bureau YA, Brown R. Placental mesenchymal dysplasia and an estimation of the population incidence. Acta Obstet Gynecol Scand 2012; 91(6): 754-757.

5. Pham T, Steele J, Stayboldt C, Chan L, Benirschke K. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature. Am J Clin Pathol 2006; 126(1): 67- 78.

6. Woo GW, Rocha FG, Gaspar-Oishi M, Bartholomew ML, Thompson KS. Placental mesenchymal dysplasia. Am J Obstet Gynecol 2011; 205(6): e3-5.

7. Cohen MC, Roper EC, Sebire NJ, Stanek J, Anumba DO. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn 2005; 25(3): 187-192.

8. Mungen E, Dundar O, Muhcu M, Haholu A, Tunca Y. Placental mesenchymal dysplasia associated with trisomy 13: sonographic findings. J Clin Ultrasound 2008; 36(7): 454-456.

9. Johnson SL, Walters-Sen LC, Stanek JW. Placental pathology in placental mesenchymal dysplasia with 13q12.11 deletion and a 25-week gestation female infant. American J Case Rep 2018; 19: 369-373.

10. Francis B, Hallam L, Kecskes Z, Ellwood D, Croaker D, Kent A. Placental mesenchymal dysplasia associated with hepatic mesenchymal hamartoma in the newborn. Pediatr Dev Pathol 2007; 10(1): 50-54.

11. Lin J, Cole BL, Qin X, Zhang M, Kapur RP. Occult androgenetic-biparental mosaicism and sporadic hepatic mesenchymal hamartoma. Pediatr Dev Pathol 2011; 14(5): 360-369.

12. Faye-Petersen OM, Kapur RP. Placental mesenchymal dysplasia. Surg Pathol Clin 2013; 6(1): 127-151.

13. Ohira S, Ookubo N, Tanaka K, et al. Placental mesenchymal dysplasia: chronological observation of placental images during gestation and review of the literature. Gynecol Obstet Invest 2013; 75(4): 217-223.

14. Nayeri UA, West AB, Grossetta Nardini HK, Copel JA, Sfakianaki AK. Systematic review of sonographic findings of placental mesenchymal dysplasia and subsequent pregnancy outcome. Ultrasound Obstet Gynecol 2013; 41(4): 366-374.

15. Simeone S, Franchi C, Marchi L, et al. Management of placental mesenchymal dysplasia associated with fetal anemia and IUGR. Eur J Obstet Gynecol Reprod Biol 2015; 184: 132-134.

16. Pawoo N, Heller DS. Placental mesenchymal dysplasia. Arch Pathol Lab Med 2014; 138(9): 1247-1249.

17. Himoto Y, Kido A, Minamiguchi S, et al. Prenatal differential diagnosis of complete hydatidiform mole with a twin live fetus and placental mesenchymal dysplasia by magnetic resonance imaging. J Obstet Gynaecol Res 2014; 40(7): 1894-1900.

18. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006; 43(2): 187-192.

19. Hoffner L, Dunn J, Esposito N, Macpherson T, Surti U. P57/KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol 2008; 39(1): 63-72.

20. Lewis GH, DeScipio C, Murphy KM, et al. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Int J Gynecol Pathol 2013; 32(2): 199-214.

21. Linn RL, Minturn L, Yee LM, et al. Placental mesenchymal dysplasia without fetal development in a twin gestation: a case report and review of the spectrum of androgenetic biparental mosaicism. Pediatr Dev Pathol 2015; 18(2): 146-154.

22. Armes JE, McGown I, Williams M, et al. The placenta in Beckwith-Wiedemann syndrome: genotype-phenotype associations, excessive extravillous trophoblast and placental mesenchymal dysplasia. Pathology (Phila) 2012; 44(6): 519-527.

23. Duffy KA, Cielo CM, Cohen JL, et al. Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management. Am J Med Genet C Semin Med Genet 2019; 181(4): 693-708.

24. Umazume T, Kataoka S, Kamamuta K, et al. Placental mesenchymal dysplasia, a case of intrauterine sudden death of fetus with rupture of cirsoid periumbilical chorionic vessels. Diagn Pathol 2011; 6: 38.

25. Psarris A, Sindos M, Kourtis P, et al. Placental mesenchymal dysplasia: ultrasound characteristics and diagnostic pitfalls. Ultrasound Int Open 2020; 6(1): e2-e3.

26. Matsuoka S, Thompson JS, Edwards MC, et al. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57/KIP2, on chromosome 11p15. Proc Natl Acad Sci U S A 1996; 93(7): 3026-3030.

27. Voloshchuk IN, Barinova IV, Chechneva MA, et al. Placental mesenchymal dysplasia. Arkh Patol 2019; 81(4): 17-25.

28. Lindor NM, Ney JA, Gaffey TA, Jenkins RB, Thibodeau SN, Dewald GW. A genetic review of complete and partial hydatidiform moles and nonmolar triploidy. Mayo Clin Proc 1992; 67(8): 791-799.

29. Candelier JJ. The hydatidiform mole. Cell Adh Migr 2016; 10(1-2): 226-235.

30. McNally L, Rabban JT, Poder L, Chetty S, Ueda S, Chen LM. Differentiating complete hydatidiform mole and coexistent fetus and placental mesenchymal dysplasia: A series of 9 cases and review of the literature. Gynecol Oncol Rep 2021; 37: 100811.

31. Steller MA, Genest DR, Bernstein MR, Lage JM, Goldstein DP, Berkowitz RS. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. Obstet Gynecol 1994; 83(1): 35-42.

32. Uemura N, Takai Y, Mikami Y, et al. Molecular cytogenetic analysis of a hydatidiform mole with coexistent fetus: a case report. J Med Case Rep 2019; 13(1): 256.

33. Keep D, Zaragoza MV, Hassold T, Redline RW. Very early complete hydatidiform mole. Hum Pathol 1996; 27(7): 708-713.

34. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol 2003; 6(1): 69-77.

35. Fisher RA, Nucci MR, Thaker HM, Weremowicz S, Genest DR, Castrillon DH. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 2004; 17(9): 1155- 1160.

36. McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 2009; 33(9): 1409-1415.

37. Kliman HJ, Segel L. The placenta may predict the baby. J Theor Biol 2003; 225(1): 143-145.

38. Redline RW, Zaragoza M, Hassold T. Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions. Hum Pathol 1999; 30(1): 93-100.

39. Redline RW, Hassold T, Zaragoza MV. Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. Hum Pathol 1998; 29(5): 505-511.

40. Redline RW, Hassold T, Zaragoza M. Determinants of villous trophoblastic hyperplasia in spontaneous abortions. Mod Pathol 1998; 11(8): 762-768.

41. Ornoy A, Salamon-Arnon J, Ben-Zur Z, Kohn G. Placental findings in spontaneous abortions and stillbirths. Teratology 1981; 24(3): 243-252.

42. Pierce BT, Martin LS, Hume RF, Jr., Calhoun BC, Muir-Padilla J, Salafia CM. Relationship between the extent of histologic villous mineralization and stillbirth in aneuploid and euploid fetuses. J Soc Gynecol Investig 2002; 9(5): 290-293.

43. Angelico G, Spadola S, Ieni A, et al. Hemangioma of the umbilical cord with associated amnionic inclusion cyst: two uncommon entities occurring simultaneously. Pathologica 2019; 111(1): 13-17.

44. Jacques SM, Qureshi F. Hemangioma of the umbilical cord with amnionic epithelial inclusion cyst. Fetal Pediatr Pathol 2013; 32(3): 235- 239.

45. Wasmoen TL, Coulam CB, Benirschke K, Gleich GJ. Association of immunoreactive eosinophil major basic protein with placental septa and cysts. Am J Obstet Gynecol 1991; 165(2): 416-420.

46. Hong SC, Yoo SW, Kim T, et al. Prenatal diagnosis of a large subchorionic placental cyst with intracystic hematomas. A case report. Fetal Diagn Ther 2007; 22(4): 259-263.

47. Bonasoni MP, Comitini G, Blasi I, Cavazza A, Aguzzoli L. Large subchorionic cyst located at umbilical cord insertion with vascular displacing and intracystic hemorrhage/hematoma: a case report. Fetal Pediatr Pathol 2020; In press.

48. Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group consensus statement. Arch Pathol Lab Med 2016; 140(7): 698-713.

49. Redline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995; 26(6): 594-600.

50. Stanek J. Placental membrane and placental disc microscopic chorionic cysts share similar clinicopathologic associations. Pediatr Dev Pathol 2011; 14(1): 1-9.

51. Stanek J. Placental membrane laminar necrosis and chorionic microcysts. Pediatr Dev Pathol 2012; 15(6): 514-516.